<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xml:lang="en" lang="en" xmlns="http://www.w3c.org/1999/xhtml" xmlns:dt="urn:schemas-microsoft-com:datatypes">
  <head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <style type="text/css">
                  BODY { 	FONT: 75% Verdana, Arial, Helvetica, sans-serif;
                  BORDER-TOP-STYLE: none;
                  BORDER-RIGHT-STYLE: none;
                  BORDER-LEFT-STYLE: none;
                  TEXT-ALIGN: left;
                  BORDER-BOTTOM-STYLE: none;
                  }

                  H1 {	FONT-FAMILY: "Trebuchet MS", Arial, sans-serif;
                  MARGIN-TOP: 0px;
                  FONT-WEIGHT: normal;
                  FONT-SIZE: 2em;
                  PADDING-BOTTOM: 10px;
                  COLOR: #0c5205
                  }

                  H2 {	FONT-FAMILY: "Trebuchet MS", Arial, sans-serif;
                  FONT-WEIGHT: normal;
                  FONT-SIZE: 1.6em;
                  COLOR: #0c5205
                  }

                  H3 {	FONT-FAMILY: "Trebuchet MS", Arial, sans-serif;
                  FONT-WEIGHT: normal;
                  FONT-SIZE: 1.5em;
                  COLOR: #000
                  }

                  H4 {	FONT-FAMILY: "Trebuchet MS", Arial, sans-serif;
                  FONT-WEIGHT: bold;
                  FONT-SIZE: 1.3em;
                  COLOR: #000
                  }

                  H5 {	FONT-WEIGHT: bold;
                  FONT-SIZE: 1em;
                  COLOR: #000;
                  FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif
                  }

                  H5.specialnote {	FONT-WEIGHT: bold;
                  FONT-STYLE: italic;
                  FONT-SIZE: 1.2em;
                  COLOR: #000;
                  FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif;
                  }

                  A {COLOR:#0a29a5;
                  TEXT-DECORATION: none}

                  P {	FONT-SIZE: 1em;
                  PADDING-RIGHT: 0px;
                  PADDING-LEFT: 0px;
                  PADDING-BOTTOM: 0px;
                  PADDING-TOP: 0px;
                  MARGIN: 0px 3em 1em;
                  LINE-HEIGHT: 1.33em;
                  TEXT-ALIGN: left;
                  FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif;
                  }

                  UL {	PADDING-RIGHT: 0px;
                  PADDING-LEFT: 0px;
                  PADDING-BOTTOM: 0px;
                  PADDING-TOP: 0px;
                  MARGIN: 0px 3.5em 1em;
                  LIST-STYLE-TYPE: disc
                  }

                  UL LI {	PADDING-RIGHT: 0px;
                  PADDING-LEFT: 0px;
                  PADDING-BOTTOM: 0px;
                  PADDING-TOP: 0px;
                  MARGIN-LEFT: 1.5em;
                  MARGIN-TOP: 0.7em;
                  MARGIN-BOTTOM: 0.7em
                  }

                  OL {	PADDING-RIGHT: 0px;
                  PADDING-LEFT: 0px;
                  PADDING-BOTTOM: 0px;
                  MARGIN: 0px;
                  PADDING-TOP: 0px;
                  PADDING-LEFT: 2em;
                  OVERFLOW: hidden;
                  LIST-STYLE-TYPE: decimal
                  }

                  OL LI {	PADDING-RIGHT: 0px;
                  PADDING-LEFT: 0px;
                  PADDING-BOTTOM: 0px;
                  PADDING-TOP: 0px;
                  MARGIN-LEFT: 1.5em;
                  MARGIN-TOP: 0.7em;
                  MARGIN-BOTTOM: 0.7em
                  }

                  TABLE {	BORDER-RIGHT: #000 1px solid;
                  PADDING-RIGHT: 2px;
                  BORDER-TOP: #000 1px solid;
                  PADDING-LEFT: 2px;
                  PADDING-BOTTOM: 2px;
                  BORDER-LEFT: #000 1px solid;
                  PADDING-TOP: 2px;
                  BORDER-BOTTOM: #000 1px solid;
                  MAX-WIDTH: 600px;
                  MARGIN: 0px auto 1em;
                  BORDER-COLLAPSE: collapse;
                  TABLE-LAYOUT: auto;
                  page-break-inside: avoid;
                  }

                  th {	BORDER: #000 1px solid;
                  PADDING: 5px;
                  VERTICAL-ALIGN: bottom;
                  TEXT-ALIGN: center;
                  FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif;
                  background: #f4f4e1; /*#f4f4e1*/
                  }

                  TD {	BORDER: #000 1px solid;
                  PADDING-RIGHT: 5px;
                  PADDING-LEFT: 5px;
                  PADDING-BOTTOM: 5px;
                  VERTICAL-ALIGN: top;
                  PADDING-TOP: 5px;
                  TEXT-ALIGN: left;
                  FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif;
                  }

                  td.values2 { text-align: RIGHT ; vertical-align:top;

                  }

                  TABLE CAPTION {	FONT-WEIGHT: normal;
                  FONT-SIZE: 1.6em;
                  PADDING-BOTTOM: 0.5em;
                  FONT-FAMILY: Trebuchet MS, Arial, sans-serif
                  }


                  div#LocatorRecord {width: 650px;
                  border-color: #999;
                  border-style:solid;
                  border-width: thin;
                  padding: 5px;
                  margin-bottom: 10px;
                  margin-top: 10px;
                  page-break-after:always
                  }
                  div#wrapper {width: 650px;}

                  div#toc {position: fixed; overflow: scroll; height: 95%; top:10px; left:700px; float:left; z-index:10;border-color:#CCC; border-style: solid; border-width:1px;}
                  div#toc h3 {background-color:#f4f4e1; padding:3px}
                  div#toc ul, li {margin-left: 3px; margin-right: 5px;}
                  div#PageHeader {width: 650px;
                  border-bottom: thin solid #999;}
                  div#Sections {width: 650px;}
                  div#Codebook {width: 650px;}
                  div#Codebook dl {width: 600px; margin: 2em 0 10px 40px ;padding: 0;}
                  div#Codebook dt {width: 150px;float: left;margin: 0 0 0 0;padding: .5em;font-weight: bold;}
                  div#Codebook dd {float: left;width: 420px;margin: 0 0 0 0;padding: .5em;}
                  div#References {width: 650px;page-break-after: always}
                  div#Appendix {width: 650px;page-break-after: always}
                  table.info {width:600px;
                  display:block;
                  border: 3px;
                  inset: #000000;
                  position: relative;
                  left: 20px;
                  margin-bottom: 20px;
                  page-break-inside: avoid;
                  }
                  table.values   {width:600px;
                  display:block;
                  border: 2px;
                  inset: #000000;
                  position: relative;
                  left: 20px;
                  margin-bottom: 20px;
                  page-break-inside: avoid;
                  }

                  .pagebreak {display: block;
                  page-break-after: always;
                  page-break-inside: avoid;}
                  .pagebreak H3 {background-color: #c1d5b0
                  }
                </style>
    <style media="print" type="text/css">
                    div#toc {display: none;}
                    div#LocatorRecord {width: 650px;
                    border-color: #999;
                    border-style:solid;
                    border-width: thin;
                    padding: 5px;
                    margin-bottom: 10px;
                    margin-top: 300px;
                    page-break-after:always
                    }
                </style>
    <script language="javascript" type="text/javascript"><!--
                        
                    function toggle(element) {
                        var nSpan = document.getElementById(element);
                            if (nSpan.style.display == 'none') {
	                        nSpan.style.display = 'block';
	                        }
                            else {
	                        nSpan.style.display = 'none'
	                        }
                    }    
                        
                        
                    function fixPageBreaks() {
                    if (navigator.appName != 'Netscape')
						{
                    var oDiv = document.getElementById('Codebook');
                    if (oDiv.firstChild) {
                    var cbkTitle = oDiv.firstChild;
                    var oChild = cbkTitle.nextSibling;
                    //var pChild = oChild.nextSibling;

                    while (oChild) {

                    if (oChild.nodeType == 1) {
                    var pChild = oChild.nextSibling;
                    var boxHeight = oChild.offsetHeight;
                    var boxHeight2 = pChild.offsetHeight;
                    totalHeight = boxHeight + boxHeight2;
                    //alert(totalHeight);

                    if (totalHeight < 850) {
                        //alert("Height is less than 850")
                        //oChild.style.backgroundColor = '#cccccc';
                        oChild.style.pageBreakAfter = 'auto';

                        if (pChild.nextSibling) {
                            oChild = pChild.nextSibling;
                            if (oChild.nextSibling) { }
                            else { oChild.pageBreakAfter = 'auto'; break; }
                        }
                        else { oChild.pageBreakAfter = 'auto'; pChild.pageBreakAfter = 'auto'; break; }


                    }
                    else {
                        //alert("Height is more than 850")
                        if (oChild.nextSibling) { oChild = oChild.nextSibling; }
                        else { oChild.pageBreakAfter = 'auto'; break;}
                        if (pChild.nextSibling) { /*pChild = pChild.nextSibling;*/ }
                        else { oChild.pageBreakAfter = 'auto'; pChild.pageBreakAfter = 'auto'; break;}
                    }
                }
            }
        }
        }
    }
    
     
    --></script><!----><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="Keywords" content="Surveys,Data Collection,NCHS,NHANES,National Health and Nutrition Examination Survey,data,documentation,Hepatitis C: confirmed antibody, Hepatitis C RNA (HCV-RNA), and Hepatitis HCV genotype " />
    <meta name="DC.Subject" content="NHANES 2007-2008: Hepatitis C: confirmed antibody, Hepatitis C RNA (HCV-RNA), and Hepatitis HCV genotype  Data Documentation" />
    <meta name="DC.Language" scheme="ISO 639-2" content="eng" />
    <link rel="Prev" Title="NHANES  2007-2008 Laboratory page" href="http://www.cdc.gov/nchs/nhanes/2007-2008/nhanes07_08.htm">
      <title>
                        NHANES 2007 - 2008: Hepatitis C: confirmed antibody, Hepatitis C RNA (HCV-RNA), and Hepatitis HCV genotype  Data Documentation, Codebook, and Frequencies
                    </title>
    </link>
  </head>
  <body onLoad="fixPageBreaks()">
    <div id="toc">
      <h3>Table of Contents</h3>
      <ul>
        <li>
          <a href="HEPC_E.htm#Component_Description">Component Description</a>
        </li>
        <li>
          <a href="HEPC_E.htm#Eligible_Sample">Eligible Sample</a>
        </li>
        <li>
          <a href="HEPC_E.htm#Description_of_Laboratory_Methodology">Description of Laboratory Methodology</a>
        </li>
        <li>
          <a href="HEPC_E.htm#Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</a>
        </li>
        <li>
          <a href="HEPC_E.htm#Data_Processing_and_Editing">Data Processing and Editing</a>
        </li>
        <li>
          <a href="HEPC_E.htm#Analytic_Notes">Analytic Notes</a>
        </li>
        <li>
          <a href="#References">References</a>
        </li>
        <li>Codebook
                        <div id="CodebookLinks">
            <ul>
              <li>
                <a href="HEPC_E.htm#SEQN">SEQN - Respondent sequence number</a>
              </li>
              <li>
                <a href="HEPC_E.htm#LBDHCV">LBDHCV - Hepatitis C antibody (confirmed)</a>
              </li>
              <li>
                <a href="HEPC_E.htm#LBXHCR">LBXHCR - Hepatitis C RNA (HCV-RNA)</a>
              </li>
              <li>
                <a href="HEPC_E.htm#LBXHCG">LBXHCG - Hepatitis HCV genotype</a>
              </li>
            </ul>
          </div>
        </li>
      </ul>
    </div>
    <div id="wrapper">
      <div id="PageHeader" xmlns="">
        <h1>
                National Health and Nutrition Examination Survey
            </h1>
        <h2>2007 - 2008 Data Documentation, Codebook, and Frequencies
            </h2>
        <h3>Hepatitis C: confirmed antibody, Hepatitis C RNA (HCV-RNA), and Hepatitis HCV genotype  (HEPC_E)
            </h3>
        <h4>
                Data File: HEPC_E.xpt
            </h4>
        <h5 class="left">
                First Published: September, 2009</h5>
        <h5 class="right">
                Last Revised:  
                        NA
                    </h5>
      </div>
      <div id="LocatorRecord" xmlns="">
        <h2>Locator Record</h2>
        <p><b>Title: </b>Hepatitis C: confirmed antibody, Hepatitis C RNA (HCV-RNA), and Hepatitis HCV genotype 
                (HEPC_E
                )<br><b>Contact Number: </b>1-866-441-NCHS<br><b>Years of Content: </b>2007
                - 2008<br><b>First Published: </b>September, 2009<br><b>Revised: </b>
                        NA
                    <br><b>Access Constraints: </b>None<br><b>Use Constraints: </b>None<br><b>Geographic Coverage: </b>National<br><b>Subject:</b>Recommendations have also been developed for the prevention and control of hepatitis C virus (HCV) infection. Because of the high rate of asymptomatic infection with these viruses, information about the prevalence of these diseases is needed to monitor prevention efforts.<br><b>Record Source: </b>NHANES 2007
                - 2008<br><b>Survey Methodology: </b>NHANES 2007
                - 2008
                is a stratified multistage probability sample of the civilian non-institutionalized population of the U.S.<br><b>Medium: </b>NHANES Web site; SAS transport files
            </p>
      </div>
      <div id="Sections" xmlns="">
        <h2><a name="Component_Description"></a>Component Description</h2><p>Hepatitis viruses constitute a major public health problem because of the morbidity and mortality associated with the acute and chronic consequences of these infections. New immunization strategies have been developed to eliminate the spread of hepatitis B virus (HBV) and hepatitis A virus (HAV) in the United States. Recommendations have also been developed for the prevention and control of hepatitis C virus (HCV) infection. Because of the high rate of asymptomatic infection with these viruses, information about the prevalence of these diseases is needed to monitor prevention efforts. By testing a nationally representative sample of the U.S. population, NHANES will provide the most reliable estimates of age-specific prevalence needed to evaluate the effectiveness of the strategies to prevent these infections. In addition, NHANES provides the means to better define the epidemiology of other hepatitis viruses. NHANES testing for markers of infection with hepatitis viruses will be used to determine secular trends in infection rates across most age and racial/ethnic groups, and will provide a national picture of the epidemiologic determinants of these infections.</p>
<h2><a name="Eligible_Sample"></a>Eligible Sample</h2><p>All participants aged 6 years and older are eligible to be tested.</p>
<h2><a name="Description_of_Laboratory_Methodology"></a>Description of Laboratory Methodology</h2><p>Blood specimens are processed, stored, and shipped to the Division of Viral Hepatitis, National Center for Infectious Diseases, National Centers for Disease Control and Prevention. Detailed specimen collection and processing instructions are discussed in the NHANES Laboratory/Medical Technologists Procedures Manual (LPM).</p>
<span style="font-size: 16px; font-family: times new roman;"></span>
<p ><strong>Hepatitis C Antibody</strong></p>
<p>Qualitative determination of the human antibody directed against hepatitis C virus (anti-HCV) in human serum or plasma is measured using direct solid-phase enzyme immunoassay with the anti-HCV screening ELISA. Positive specimens are repeated in duplicate according to the same procedure. Repeatedly positive specimens are tested supplementally using the Chiron RIBA Processor System (Chiron Corporation, Inc.). </p>
<p><strong>The Chiron RIBA HCV 3.0 Strip (confirmation test)</strong></p>
<p>The Chiron RIBA 3.0 Strip Immunoblot Assay (SIA; Chiron Corporation, Inc.) is an in vitro qualitative enzyme immunoassay for the detection of antibody to hepatitis C virus (anti-HCV) in human serum or plasma.</p>
<p>Detection of anti-HCV by SIA methodology is based upon traditional Western and dot blotting techniques, in which specific immunogens (i.e. antigenic polyproteins) encoded by the HCV genome are immobilized onto a membrane support. Visualization of anti-HCV reactivity in specimens to the individual HCV-encoded proteins is accomplished with anti-human IgG enzyme-conjugates in conjunction with a colorimetric enzyme substrate.  Samples where the RIBA result was positive are reported as confirmed positive for antibody to HCV. Samples where the RIBA result was negative are reported as negative for antibody to HCV and indeterminate results are reported as indeterminate. </p>
<p><strong>Hepatitis C RNA (HCV-RNA)</strong></p>
<p>The COBAS AMPLICOR HCV MONITOR Test, version 2 0 (v2.0) is an in vitro nucleic acid amplification test for the quantitation of Hepatitis C Virus RNA in human serum or plasma on the COBAS AMPLICOR Analyzer.</p>
<p><strong>Hepatitis HCV genotype </strong></p>
<p>The VERSANT ® HCV Genotype 2.0 Assay (LiPA) is a line probe assay designed to identify Hepatitis C virus (HCV) genotypes 1 to 6 in human serum or EDTA plasma samples. Subtype information is available in the majority of cases.</p>
<p>There were no changes (from the previous 2 years of NHANES) to equipment, lab methods or lab site.  However, positive Hepatitis C results were further tested using RNA and HCV genotyping in 2007-2008.</p>
<p>A detailed description of the laboratory methods used can be found on the NHANES website. </p>
<h2><a name="Data_Processing_and_Editing"></a>Data Processing and Editing</h2><p>Read the General Documentation on Laboratory Data file for detailed data processing and editing protocols. The analytical methods are described in the Description of Laboratory Methodology section above.</p>
<h2><a name="Laboratory_Quality_Assurance_and_Monitoring"></a>Laboratory Quality Assurance and Monitoring</h2><p>The NHANES quality assurance and quality control (QA/QC) protocols meet the 1988 Clinical Laboratory Improvement Act mandates. Detailed quality control and quality assurance instructions are discussed in the NHANES Laboratory/Medical Technologists Procedures Manual (LPM). Read the General Documentation on Laboratory Data file for detailed QA/QC protocols.  A detailed description of the quality assurance and quality control procedures can be found on the NHANES website.</p>
<h2><a name="Analytic_Notes"></a>Analytic Notes</h2><p>The analysis of NHANES laboratory data must be conducted with the key survey design and basic demographic variables. The NHANES Household Questionnaire Data Files contain demographic data, health indicators, and other related information collected during household interviews. They also contain all survey design variables and sample weights for these age groups. The phlebotomy file includes auxiliary information such as the conditions precluding venipuncture. The household questionnaire and phlebotomy files may be linked to the laboratory data file using the unique survey participant identifier SEQN.</p>
<p>The age range and constraints for hepatitis testing are as follows:</p>
<p>Hep C-The screening hepatitis C antibody test is performed on all examinees 6 years old and older. Samples testing positive for anti-HCV by the screening EIA test were tested in the confirmatory RIBA assay for antibody to hepatitis C virus. Samples where the RIBA result was positive are reported as confirmed positive for antibody to HCV. Samples where the RIBA result was negative are reported as negative for antibody to HCV.  Samples where the RIBA result is indeterminate are reported out as such and subsequently tested for HCV RNA to attempt to confirm the infection status of the patient.  Samples that tested negative by the screening EIA test were not tested by RIBA. These samples were reported as negative for antibody to HCV.  Samples that tested positive or indeterminate by the HCV RNA were subsequently tested for HCV genotyping.</p>
<p>Exam sample weights should be used for analyses. Please refer to the Analytic Guidelines for further details on the use of sample weights and other analytic issues.  The Analytic Guidelines are available on the NHANES website. </p>
</div>
      <div id="References" xmlns=""><a name="References"></a><h2>References</h2>
        <ul>N/A.</ul>
      </div>
      <div id="Codebook" xmlns="">
        <h2>Codebook and Frequencies</h2>
        <div class="pagebreak">
          <h3><a name="SEQN"></a>SEQN - Respondent sequence number</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SEQN</dd>
            <dt>SAS Label: </dt>
            <dd>Respondent sequence number</dd>
            <dt>English Text: </dt>
            <dd class="info">Respondent sequence number.</dd>
            <dt>Target Gender: </dt>
            <dd> Both males and females</dd>
            <dt>Target Age: </dt>
            <dd>6 YEARS - 150 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3><a name="LBDHCV"></a>LBDHCV - Hepatitis C antibody (confirmed)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBDHCV</dd>
            <dt>SAS Label: </dt>
            <dd>Hepatitis C antibody (confirmed)</dd>
            <dt>English Text: </dt>
            <dd class="info">Hepatitis C antibody (confirmed)</dd>
            <dt>Target Gender: </dt>
            <dd> Both males and females</dd>
            <dt>Target Age: </dt>
            <dd>6 YEARS - 150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th class="values">Code or Value</th>
                <th class="values">Value Description</th>
                <th class="values">Count</th>
                <th class="values">Cumulative</th>
                <th class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <th class="values">1</th>
                <td class="values">Positive</td>
                <td class="values" align="right">114</td>
                <td class="values" align="right">114</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <th class="values">2</th>
                <td class="values">Negative</td>
                <td class="values" align="right">7280</td>
                <td class="values" align="right">7394</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <th class="values">5</th>
                <td class="values">Indeterminate</td>
                <td class="values" align="right">16</td>
                <td class="values" align="right">7410</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <th class="values">.</th>
                <td class="values">Missing</td>
                <td class="values" align="right">722</td>
                <td class="values" align="right">8132</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3><a name="LBXHCR"></a>LBXHCR - Hepatitis C RNA (HCV-RNA)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXHCR</dd>
            <dt>SAS Label: </dt>
            <dd>Hepatitis C RNA (HCV-RNA)</dd>
            <dt>English Text: </dt>
            <dd class="info">Hepatitis C RNA (HCV-RNA)</dd>
            <dt>Target Gender: </dt>
            <dd> Both males and females</dd>
            <dt>Target Age: </dt>
            <dd>6 YEARS - 150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th class="values">Code or Value</th>
                <th class="values">Value Description</th>
                <th class="values">Count</th>
                <th class="values">Cumulative</th>
                <th class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <th class="values">1</th>
                <td class="values">Positive</td>
                <td class="values" align="right">88</td>
                <td class="values" align="right">88</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <th class="values">2</th>
                <td class="values">Negative</td>
                <td class="values" align="right">33</td>
                <td class="values" align="right">121</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <th class="values">.</th>
                <td class="values">Missing</td>
                <td class="values" align="right">8011</td>
                <td class="values" align="right">8132</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3><a name="LBXHCG"></a>LBXHCG - Hepatitis HCV genotype</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXHCG</dd>
            <dt>SAS Label: </dt>
            <dd>Hepatitis HCV genotype</dd>
            <dt>English Text: </dt>
            <dd class="info">Hepatitis HCV genotype</dd>
            <dt>Target Gender: </dt>
            <dd> Both males and females</dd>
            <dt>Target Age: </dt>
            <dd>6 YEARS - 150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th class="values">Code or Value</th>
                <th class="values">Value Description</th>
                <th class="values">Count</th>
                <th class="values">Cumulative</th>
                <th class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <th class="values">1</th>
                <td class="values">Positive</td>
                <td class="values" align="right">75</td>
                <td class="values" align="right">75</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <th class="values">2</th>
                <td class="values">Negative</td>
                <td class="values" align="right">13</td>
                <td class="values" align="right">88</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <th class="values">3</th>
                <td class="values">Undetermined</td>
                <td class="values" align="right">0</td>
                <td class="values" align="right">88</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <th class="values">.</th>
                <td class="values">Missing</td>
                <td class="values" align="right">8044</td>
                <td class="values" align="right">8132</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
    </div>
  </body>
</html>